Vidya Arankalle
#134,591
Most Influential Person Now
Indian virologist
Vidya Arankalle's AcademicInfluence.com Rankings
Vidya Arankallebiology Degrees
Biology
#9110
World Rank
#12275
Historical Rank
Virology
#384
World Rank
#392
Historical Rank
Microbiology
#483
World Rank
#544
Historical Rank
Download Badge
Biology
Why Is Vidya Arankalle Influential?
(Suggest an Edit or Addition)According to Wikipedia, Vidya Avinash Arankalle is an Indian virologist whose work is multidisciplinary, incorporating aspects of cell culture and microbiology. Life She is a fellow of the Indian National Science Academy, and the Indian Academy of Sciences.
Vidya Arankalle's Published Works
Published Works
- Chikungunya Outbreaks Caused by African Genotype, India (2006) (334)
- Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. (1995) (317)
- Genetic divergence of Chikungunya viruses in India (1963-2006) with special reference to the 2005-2006 explosive epidemic. (2007) (292)
- Thermal stability of hepatitis E virus. (2005) (226)
- Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent. (1994) (193)
- Prevalence of anti‐hepatitis E virus antibodies in different Indian animal species (2001) (183)
- West Nile virus isolates from India: evidence for a distinct genetic lineage. (2007) (179)
- A large outbreak of acute encephalitis with high fatality rate in children in Andhra Pradesh, India, in 2003, associated with Chandipura virus (2004) (169)
- Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. (2009) (167)
- Human and swine hepatitis E viruses from Western India belong to different genotypes. (2002) (137)
- Genomic Characterization of Nipah Virus (2011) (135)
- AETIOLOGICAL ASSOCIATION OF A VIRUS-LIKE PARTICLE WITH ENTERICALLY TRANSMITTED NON-A, NON-B HEPATITIS (1988) (135)
- Genomic Characterization of Nipah Virus, West Bengal, India (2011) (129)
- Retrospective Analysis of Blood Transfusion Recipients: Evidence for Post–Transfusion Hepatitis E (2000) (126)
- Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay. (2006) (117)
- Hepatitis B virus genotypes and serotypes in western India: Lack of clinical significance (2003) (114)
- Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982–98) (2001) (109)
- An outbreak of Chandipura virus encephalitis in the eastern districts of Gujarat state, India. (2005) (107)
- Phylogenetic analysis of hepatitis E virus isolates from India (1976-1993). (1999) (107)
- Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus. (2012) (101)
- Role of Host Immune Response and Viral Load in the Differential Outcome of Pandemic H1N1 (2009) Influenza Virus Infection in Indian Patients (2010) (92)
- Molecular characterization of hepatitis A virus from a large outbreak from Kerala, India. (2006) (92)
- Polymerase chain reaction-based prevalence of hepatitis A, hepatitis E and TT viruses in sewage from an endemic area. (2002) (90)
- Viral Load, Antibody Titers and Recombinant Open Reading Frame 2 Protein-Induced Th1/Th2 Cytokines and Cellular Immune Responses in Self-Limiting and Fulminant Hepatitis E (2009) (84)
- Hepatitis E virus: can it be transmitted parenterally? (1999) (82)
- Comparison of Hepatitis C Virus Genotyping by 5′ Noncoding Region- and Core-Based Reverse Transcriptase PCR Assay with Sequencing and Use of the Assay for Determining Subtype Distribution in India (2003) (77)
- Venereal transmission of chikungunya virus by Aedes aegypti mosquitoes (Diptera: Culicidae). (2010) (67)
- Evolutionary rates and timescale comparison of Chikungunya viruses inferred from the whole genome/E1 gene with special reference to the 2005-07 outbreak in the Indian subcontinent. (2009) (67)
- Antibodies against hepatitis E virus in old world monkeys (1994) (66)
- Comparison of etiology of sporadic acute and fulminant viral hepatitis in hospitalized patients in Pune, India during 1978-81 and 1994-97. (2003) (66)
- Chandipura virus encephalitis outbreak among children in Nagpur division, Maharashtra, 2007. (2010) (66)
- Administration of E2 and NS1 siRNAs Inhibit Chikungunya Virus Replication In Vitro and Protects Mice Infected with the Virus (2013) (66)
- Type‐IV Indian swine HEV infects rhesus monkeys (2006) (65)
- Vertical transmission of Hepatitis A (2002) (65)
- Analysis of Antiviral Response in Human Epithelial Cells Infected with Hepatitis E Virus (2013) (64)
- Co-circulation of all the four dengue virus serotypes and detection of a novel clade of DENV-4 (genotype I) virus in Pune, India during 2016 season (2018) (64)
- Role of immune serum globulins in pregnant women during an epidemic of hepatitis E (1998) (60)
- Fulminant hepatic failure: etiology, viral markers and outcome. (1999) (57)
- Prevalence and incidence of hepatitis B virus infection in STD clinic attendees in Pune, India (2002) (55)
- Cross‐challenge studies in rhesus monkeys employing different Indian isolates of hepatitis E virus (1995) (55)
- Increased Risk of Hepatitis E in Sewage Workers from India (2003) (51)
- Hepatitis E virus infection in pregnant rhesus monkeys. (1993) (51)
- Contribution of HEV and HCV in causing fulminant non‐A, non‐B hepatitis in western India (1995) (49)
- Hepatitis E virus from India exhibits significant amino acid mutations in fulminant hepatic failure patients (2013) (48)
- Detection of Chandipura Virus from Sand Flies in the Genus Sergentomyia (Diptera: Phlebotomidae) at Karimnagar District, Andhra Pradesh, India (2005) (48)
- Hepatitis B virus: predominance of genotype D in primitive tribes of the Andaman and Nicobar islands, India (1989-1999). (2003) (47)
- Prevalence of anti-HCV antibodies in western India. (1995) (46)
- Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. (2007) (44)
- Retrospective serological analysis of hepatitis E patients: a long‐term follow‐up study (1999) (44)
- Investigation of a hepatitis A outbreak from Shimla Himachal Pradesh. (2009) (44)
- Non-A, non-B epidemic hepatitis: visualization of virus-like particles in the stool by immune electron microscopy. (1984) (44)
- Long-term serological follow up and cross-challenge studies in rhesus monkeys experimentally infected with hepatitis E virus. (1999) (42)
- Prevalence of hepatitis B infection among the primitive tribes of Andaman & Nicobar Islands. (2000) (42)
- Retrospective Analysis of Blood Transfusion Recipients: Evidence for Post‐Transfusion Hepatitis E (2000) (40)
- Quantitation of hepatitis B virus DNA by real-time PCR using internal amplification control and dual TaqMan MGB probes. (2006) (37)
- Insignificant prevalence of antibodies to hepatitis C in a rural area of western Maharashtra. (1999) (35)
- Peripheral T regulatory cells and cytokines in hepatitis E infection (2011) (35)
- A high prevalence of antibodies to hepatitis C virus among commercial plasma donors from Western India (1995) (34)
- Cytokine Profiles, CTL Response and T Cell Frequencies in the Peripheral Blood of Acute Patients and Individuals Recovered from Hepatitis E Infection (2012) (34)
- Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122 (2018) (34)
- Outbreaks of hepatitis A among children in western India. (2009) (34)
- Full genome sequence and analysis of Indian swine hepatitis E virus isolate of genotype 4. (2006) (33)
- Epidemic hepatitis E: serological evidence for lack of intrafamilial spread. (2000) (32)
- Epidemiology of hepatitis B infection among the Nicobarese – a mongoloid tribe of the Andaman and Nicobar Islands, India (2002) (32)
- Rhesus monkeys infected with hepatitis E virus (HEV) from the former USSR are immune to subsequent challenge with an Indian strain of HEV. (1993) (31)
- An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringes (2011) (31)
- Immunogenicity and safety of live attenuated hepatitis A vaccine: a multicentric study. (2009) (30)
- Expression profile of immune response genes during acute myopathy induced by chikungunya virus in a mouse model. (2012) (28)
- Whole Genomes of Chandipura Virus Isolates and Comparative Analysis with Other Rhabdoviruses (2012) (28)
- Full length genomes of genotype IIIA Hepatitis A Virus strains (1995-2008) from India and estimates of the evolutionary rates and ages. (2009) (28)
- First Detection of Human Metapneumovirus in Children with Acute Respiratory Infection in India: a Preliminary Report (2004) (26)
- Changing scenario of hepatitis A virus and hepatitis E virus exposure among the primitive tribes of Andaman and Nicobar Islands, India over the 10‐year period 1989–99 (2002) (26)
- OUTBREAK OF ENTERICALLY TRANSMITTED NON-A, NON-B HEPATITIS AMONG SCHOOLCHILDREN (1988) (26)
- Ten-year serological follow up of hepatitis B vaccine recipients. (2000) (25)
- Suppressive activity and altered conventional phenotype markers/mediators of regulatory T cells in patients with self‐limiting hepatitis E (2014) (24)
- Epidemic of Hepatitis B with high mortality in India: association of fulminant disease with lack of CCL4 and natural killer T cells (2011) (24)
- Changing epidemiology of hepatitis A virus in Indian children (2014) (24)
- Increasing Burden of Hepatitis A in Adolescents and Adults and the Need for Long-Term Protection: A Review from the Indian Subcontinent (2019) (24)
- Chandipura virus growth kinetics in vertebrate cell lines, insect cell lines & embryonated eggs. (2010) (23)
- Development of candidate combination vaccine for hepatitis E and hepatitis B: a liposome encapsulation approach. (2009) (23)
- Association of polymorphisms in the promoter regions of TNF-α (-308) with susceptibility to hepatitis E virus and TNF-α (-1031) and IFN-γ (+874) genes with clinical outcome of hepatitis E infection in India. (2011) (23)
- Hepatitis A in day care centre (1996) (22)
- Genomic characterization of Salmonella bacteriophages isolated from India (2016) (22)
- Venereal transmission of Chandipura virus by Phlebotomus papatasi (Scopoli). (2006) (21)
- Evaluation of Urine as a Clinical Specimen for Diagnosis of Hepatitis A (2002) (21)
- Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients. (2021) (21)
- Exposure of Indian children to hepatitis a virus & vaccination age (1999) (20)
- Effect of Pregnancy on Anti-HEV Antibody Titres, Plasma Cytokines and the Corresponding Gene Expression Levels in the PBMCs of Patients Presenting with Self-Recovering Clinical and Subclinical Hepatitis E (2014) (19)
- Association of HLA alleles with hepatitis C infection in Maharashtra, western India. (2009) (19)
- Hepatitis E virus (HEV)-1 harbouring HEV-4 non-structural protein (ORF1) replicates in transfected porcine kidney cells. (2016) (19)
- Who should receive hepatitis A vaccine? (2003) (19)
- Elevated Levels of Neutrophil Activated Proteins, Alpha-Defensins (DEFA1), Calprotectin (S100A8/A9) and Myeloperoxidase (MPO) Are Associated With Disease Severity in COVID-19 Patients (2021) (18)
- Identification and characterization of cellular proteins interacting with Hepatitis E virus untranslated regions. (2015) (18)
- Recombinant glycoprotein based vaccine for Chandipura virus infection. (2009) (18)
- Analysis of helicase domain mutations in the hepatitis E virus derived from patients with fulminant hepatic failure: Effects on enzymatic activities and virus replication (2014) (18)
- Development and evaluation of a real-time one step Reverse-Transcriptase PCR for quantitation of Chandipura Virus (2008) (17)
- Establishment and characterization of a new Aedes aegypti (L.) (Diptera: Culicidae) cell line with special emphasis on virus susceptibility (2009) (17)
- Stratified sero-prevalence revealed overall high disease burden of dengue but suboptimal immunity in younger age groups in Pune, India (2018) (17)
- Fecal shedding of hepatitis A virus in Indian patients with hepatitis A and in experimentally infected Rhesus monkey. (2001) (17)
- Identification of chikungunya virus interacting proteins in mammalian cells (2014) (16)
- Intracranial Administration of P Gene siRNA Protects Mice from Lethal Chandipura Virus Encephalitis (2010) (16)
- Prevalence of hepatitis a antibodies in western Indian population: changing pattern. (1999) (15)
- Development of an inactivated candidate vaccine against Chandipura virus (Rhabdoviridae: Vesiculovirus) (2011) (15)
- Immune response to an indigenously developed hepatitis-B (Shanvac-B) vaccine in a tribal community of India. (2002) (13)
- Circulation of genotype-I hepatitis B virus in the primitive tribes of Arunachal Pradesh in early sixties and molecular evolution of genotype-I. (2014) (13)
- Hepatitis E virus‐based evaluation of a virion concentration method and detection of enteric viruses in environmental samples by multiplex nested RT‐PCR (2010) (13)
- Persistence of viral RNA in chikungunya virus-infected Aedes aegypti (Diptera: Culicidae) mosquitoes after prolonged storage at 28°C. (2012) (13)
- Prevalence and Phylogenetic Analysis of TT Virus DNA in Western India (2000) (13)
- Virological evaluation of domestic water purification devices commonly used in India emphasizes inadequate quality and need for virological standards (2009) (12)
- Hepatitis G virus infection in India: prevalence and phylogenetic analysis based on 5' non-coding region. (2001) (12)
- Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination (2012) (12)
- Toll like receptors in self-recovering hepatitis E patients with or without pregnancy. (2014) (11)
- Utility of Pandemic H1N1 2009 Influenza Virus Recombinant Hemagglutinin Protein-Based Enzyme-Linked Immunosorbent Assay for Serosurveillance (2010) (11)
- Cytokine levels in Chandipura virus associated encephalopathy in children (2005) (11)
- Indigenous anti-hepatitis A virus IgM capture ELISA for the diagnosis of hepatitis A. (1994) (11)
- Prevalence of Hepatitis B and C Virus Infections among Haemodialysis Patients in Pune (Western India) (1993) (10)
- Hepatitis E antibody profiles in serum and urine (2002) (10)
- Hepatitis B seromarkers among medical and paramedical personnel. (1991) (10)
- Enhanced humoral response in pregnant mice immunized with liposome encapsulated recombinant neutralizing epitope protein of Hepatitis- E virus (2015) (10)
- Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA (2020) (10)
- Anti‐HCV Positivity among Blood Donor Population from Pune, India (1981–1994) (1995) (9)
- Disease‐duration based comparison of subsets of immune cells in SARS CoV‐2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity (2021) (9)
- Hepatitis A infection. (1995) (9)
- Sensitive ELISA tests for detection of anti-hepatitis A virus antibodies (1996) (8)
- Risk of transfusion‐associated dengue: screening of blood donors from Pune, western India (2018) (8)
- Evaluation of the immunogenicity of a recombinant glycoprotein-based Chandipura vaccine in combination with commercially available DPT vaccine. (2010) (8)
- Hepatitis delta virus infection among the tribes of the Andaman and Nicobar Islands, India. (2005) (8)
- Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India (2021) (8)
- Hepatitis E in India (2012) (8)
- Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin-A Multicenter Study. (2012) (8)
- Hepatitis A vaccine strategies and relevance in the present scenario. (2004) (7)
- Specific memory B cell response and participation of CD4+ central and effector memory T cells in mice immunized with liposome encapsulated recombinant NE protein based Hepatitis E vaccine candidate. (2016) (7)
- Standardization of ELISA for anti-chikungunya-IgG antibodies and age-stratified prevalence of anti-chikungunya-IgG antibodies in Pune, India (2020) (6)
- Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy (2021) (6)
- Detection of human parvovirus 4 DNA in the patients with acute encephalitis syndrome during seasonal outbreaks of the disease in Gorakhpur, India (2019) (6)
- Altered expressions of peripheral CD11c, CD80, CD83 markers and associations of HLA class II allele and haplotypes in self-limiting Hepatitis E infection. (2013) (6)
- Serum immunoglobulin G subclass responses in different phases of hepatitis E virus infection (2013) (6)
- DistributionAssay for Determining Subtype Assay with Sequencing and Use of the Core-Based Reverse Transcriptase PCR Noncoding Region-and ′ Genotyping by 5 Comparison of Hepatitis C Virus (2003) (6)
- Differential Immune Responses in Mice Immunized with Recombinant Neutralizing Epitope Protein of Hepatitis E Virus Formulated with Liposome and Alum Adjuvants. (2016) (6)
- The expression patterns of immune response genes in the Peripheral Blood Mononuclear cells of pregnant women presenting with subclinical or clinical HEV infection are different and trimester-dependent: A whole transcriptome analysis (2020) (5)
- Hepatitis B infection among dental personnel in Pune & Bombay (India). (1991) (5)
- Seroepidemiology of respiratory syncytial virus in western India with special reference to appropriate age for infant vaccination (2019) (5)
- Age‐stratified anti‐HAV positivity in Pune, India after two decades: Has voluntary vaccination impacted overall exposure to HAV? (2019) (5)
- Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants. (2019) (5)
- Isolation and genetic characterization of SARS-CoV-2 from Indian patients in a single family without H/O travel abroad (2021) (5)
- Seroepidemiology of hepatitis delta virus infection in Pune, India. (1992) (5)
- Association of Toll‐like receptor 4 polymorphism with hepatitis E virus‐infected Indian patients (2018) (5)
- Non A non B hepatitis epidemic in Rewa district of Madhya Pradesh. (1992) (4)
- Assessment of qPCR, Nested RT-PCR and Elisa Techniques in Diagnosis of Chikungunya (2014) (4)
- Time dependent decline of neutralizing antibody titers in COVID-19 patients from Pune, India and evidence of reinfection (2022) (4)
- Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India (2020) (4)
- Emergence of two distinct variants of SARS-CoV-2 and an explosive second wave of COVID-19: the experience of a tertiary care hospital in Pune, India (2021) (4)
- Circulating miR-122 levels in self-recovering hepatitis E patients (2019) (4)
- Exposure of STD patients and prisoners from Pune to hepatitis B and C viruses. (1997) (4)
- Envelope specific T cell responses & cytokine profiles in chikungunya patients hospitalized with different clinical presentations (2015) (3)
- Hepatitis B infection in an orphanage. (1983) (3)
- VIRUSES OF ENTERICALLY TRANSMITTED NON-A, NON-B HEPATITIS (1988) (3)
- Phenotypic analysis of monocytes and CD4+ T cells in hepatitis E patients with or without pregnancy. (2019) (3)
- Follow up of cases of enterically transmitted non-A, non-B hepatitis. (1991) (3)
- Immune Response of Indian Preterm Infants to Pentavalent Vaccine Varies With Component Antigens and Gestational Age (2021) (3)
- Complete genome sequences of hepatitis C virus subtype 3i and 3a subtype isolates from India (2010) (3)
- Necessity to vaccinate spouses of hepatitis B patients and carriers. (1990) (3)
- Detection by electron microscopy of endogenous viruses inAedes krombeini (H.) cell line (1994) (2)
- Fulminant hepatitis A in children with sickle cell disease. (2002) (2)
- Age-Dependent Evaluation of Immunoglobulin G Response after Chikungunya Virus Infection. (2021) (2)
- Evaluation of Liposome, Heat-Killed Mycobacterium w, and Alum Adjuvants in the Protection Offered by Different Combinations of Recombinant HA, NP proteins, and M2e Against Homologous H5N1 Virus. (2016) (1)
- Comparative immunogenicity of different hepatitis B vaccines among certain high risk groups in India. (1992) (1)
- Immunogenicity of Two COVID-19 Vaccines Currently Used in India: Experience in Health Care Workers From a Tertiary Care Hospital (2021) (1)
- Anti-delta antibodies in commercial immunoglobulin preparations. (1988) (1)
- Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital (2022) (1)
- Enterically Transmitted Non-A, Non-B Hepatitis : First Report Of An Outbreak In An Isolated Population (1988) (1)
- Cytokine profiles in peripheral blood mononuclear cells and sera from patients with acute self-limited hepatitis A. (2005) (1)
- Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test (2021) (1)
- Hepatitis C Virus RNA Positivity among RIBA‐3 Indeterminates (1995) (1)
- Complete genome characterization and evolutionary analysis of dengue viruses isolated during 2016-2017 in Pune, India. (2021) (0)
- Correlation of serostatus and viraemia levels among Indian dengue patients at the time of first diagnosis. (2020) (0)
- Standardization of ELISA for anti-chikungunya-IgG antibodies and age-stratified prevalence of anti-chikungunya-IgG antibodies in Pune, India (2020) (0)
- SARS-CoV-2 breakthrough infections during the second wave of COVID-19 at Pune, India (2023) (0)
- Detection of IgM against hepatitis A virus using tissue culture derived antigen. (1991) (0)
- Hepatitis E virus from India exhibits significant amino acid mutations in fulminant hepatic failure patients (2012) (0)
- Hepatitis E in India (2012) (0)
- Masthead and Table of Contents (2019) (0)
- HOW OFTEN DOES HBSAG POSITIVITY IN ACUTE VIRAL HEPATITIS MEAN ACUTE HEPATITIS B (1997) (0)
- Serologic evidence for a second epidemic non-A, non-B hepatitis agent (1993) (0)
- [A comparative study of non-A, non-B hepatitis with a fecal-oral mechanism of the transmission of the causative agent in the USSR and India]. (1990) (0)
- Current blood transfusion practices in India. (2000) (0)
- Genomic characterization of Salmonella bacteriophages isolated from India (2016) (0)
- Identification of chikungunya virus interacting proteins in mammalian cells (2014) (0)
- Thanks to our reviewers in 2015 (2016) (0)
- Virus DNA in Western India Prevalence and Phylogenetic Analysis of TT (2000) (0)
- Immunoglobulin G Subclass Response After Chikungunya Virus Infection. (2022) (0)
- O.033 Outbreaks of hepatitis A in western India: 2002–2004 (2006) (0)
- Enhanced humoral response in pregnant mice immunized with liposome encapsulated recombinant neutralizing epitope protein of Hepatitis- E virus (2015) (0)
- Peripheral T regulatory cells and cytokines in hepatitis E infection (2011) (0)
- Diagnostic significance of anti-HBc-IgM in patients of acute viral hepatitis. (1986) (0)
- P.307 Search for sporadic acute viral hepatitis cases with type-4 hepatitis E virus in western India (2006) (0)
- Evaluation of NS1-Detection-Based Cell Culture Method for Isolation of Dengue Viruses from Clinical Samples (2020) (0)
- Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination (2012) (0)
- CHIKV replication in C57BL/6 and Swiss albino mice. (2013) (0)
- Inter-Clade Protection Offered by Mw-Adjuvanted Recombinant HA, NP Proteins, and M2e Peptide Combination Vaccine in Mice Correlates with Cellular Immune Response (2017) (0)
- P.333 Molecular epidemiology of hepatitis A virus in western India (1981–2005) (2006) (0)
- Antibody response to hepatitis B vaccine in medical & paramedical personnel in India. (1987) (0)
This paper list is powered by the following services: